LTRN
Lantern Pharma·NASDAQ
--
--(--)
--
--(--)
2.86 / 10
Underperform
Technically, the stock is underperforming (score 2.86/10). Dominant bearish signals include a MACD Death Cross and frequent Long Upper/Lower Shadow patterns, indicating indecision and potential downside pressure. The scarcity of bullish indicators underscores the need for caution until a clearer trend emerges.
Analysis Checks(0/3)
Long Lower Shadow
Score3.62/10
Win Rate50.00%
Hist. Signals66
Avg Return1.23%
Score3.62/10
Win Rate50.00%
Hist. Signals66
Avg Return1.23%
MACD Death Cross
Score1.02/10
Win Rate25.00%
Hist. Signals8
Avg Return0.57%
Score1.02/10
Win Rate25.00%
Hist. Signals8
Avg Return0.57%
Long Upper Shadow
Score3.95/10
Win Rate53.16%
Hist. Signals79
Avg Return0.95%
Score3.95/10
Win Rate53.16%
Hist. Signals79
Avg Return0.95%
Long Lower Shadow
Score3.62/10
Win Rate50.00%
Hist. Signals66
Avg Return1.23%
Score3.62/10
Win Rate50.00%
Hist. Signals66
Avg Return1.23%
Long Upper Shadow
Score3.95/10
Win Rate53.16%
Hist. Signals79
Avg Return0.95%
Score3.95/10
Win Rate53.16%
Hist. Signals79
Avg Return0.95%
MACD Death Cross
Score1.02/10
Win Rate25.00%
Hist. Signals8
Avg Return0.57%
Score1.02/10
Win Rate25.00%
Hist. Signals8
Avg Return0.57%
What is the current technical signals for LTRN?
- LTRN presents a Underperform setup with a Technical Score of 2.86/10. Key technical indicators highlight an RSI of 31.82 and a MACD of -0.15, with the trend anchored by the 50-Day SMA at 3.39. Traders should monitor key support at 2.44 and resistance at 2.77.
